To examine the effect of CD56+ T cells suppressing HBV replication in human hepatocytes in vitro, HBV-producing hepatoma cell line HepG2.2.15 was co-cultured with CD3brightCD56+ or CD3dimCD56+ T cells. The gene discussed is NCAM1; the disease is hepatocellular carcinoma.